RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Arcus Biosciences Stock

Arcus Biosciences ROA 2024

Arcus Biosciences ROA

-0.28

Ticker

RCUS

ISIN

US03969F1093

WKN

A2JGDZ

In 2024, Arcus Biosciences's return on assets (ROA) was -0.28, a 41.23% increase from the -0.2 ROA in the previous year.

Arcus Biosciences Aktienanalyse

What does Arcus Biosciences do?

Arcus Biosciences Inc is a biotechnology company based in Hayward, California, which focuses on developing novel therapeutics for the treatment of cancer and other serious diseases. The company was founded in 2016 and went public in 2018. Arcus Biosciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Arcus Biosciences's Return on Assets (ROA)

Arcus Biosciences's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Arcus Biosciences's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Arcus Biosciences's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Arcus Biosciences’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Arcus Biosciences stock

What is the Return on Assets (ROA) of Arcus Biosciences this year?

The Return on Assets (ROA) of Arcus Biosciences is -0.28 undefined this year.

What was the ROA of Arcus Biosciences compared to the previous year?

The ROA of Arcus Biosciences has increased by 41.23% compared to the previous year.

What consequences do high ROA have for investors of Arcus Biosciences?

A high ROA is advantageous for investors of Arcus Biosciences, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Arcus Biosciences?

A low ROA can be unfavorable for investors of Arcus Biosciences as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Arcus Biosciences affect the company?

An increase in ROA of Arcus Biosciences can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Arcus Biosciences impact the company?

A reduction in the ROA of Arcus Biosciences can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Arcus Biosciences?

Some factors that can influence the ROA of Arcus Biosciences include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Arcus Biosciences important for investors?

The ROA of Arcus Biosciences is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Arcus Biosciences take to improve ROA?

To improve ROA, Arcus Biosciences can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Arcus Biosciences pay?

Over the past 12 months, Arcus Biosciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Arcus Biosciences is expected to pay a dividend of 0 USD.

What is the dividend yield of Arcus Biosciences?

The current dividend yield of Arcus Biosciences is .

When does Arcus Biosciences pay dividends?

Arcus Biosciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Arcus Biosciences?

Arcus Biosciences paid dividends every year for the past 0 years.

What is the dividend of Arcus Biosciences?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Arcus Biosciences located?

Arcus Biosciences is assigned to the 'Health' sector.

Wann musste ich die Aktien von Arcus Biosciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Arcus Biosciences from 9/28/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/28/2024.

When did Arcus Biosciences pay the last dividend?

The last dividend was paid out on 9/28/2024.

What was the dividend of Arcus Biosciences in the year 2023?

In the year 2023, Arcus Biosciences distributed 0 USD as dividends.

In which currency does Arcus Biosciences pay out the dividend?

The dividends of Arcus Biosciences are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Arcus Biosciences

Our stock analysis for Arcus Biosciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Arcus Biosciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.